Market Overview

Benzinga's Top Initiations

Related NPSP
NPS Pharma Initiates Phase 2a Study Of NPSP795 In Adult Patients With Autosomal Dominant Hypocalcemia (ADH)
NPS Pharma's Natpara Likely To Be Reviewed In September - Analyst Blog

Analysts at Imperial Capital initiated coverage on shares of FireEye (NASDAQ: FEYE) with an “in-line” rating. The target price for FireEye is set to $68. FireEye's shares closed at $63.50 yesterday.

Goldman Sachs initiated coverage on shares of NPS Pharmaceuticals (NASDAQ: NPSP) with a “buy” rating. The target price for NPS Pharmaceuticals is set to $45. NPS Pharma's shares closed at $27.55 yesterday.

Macquarie initiated coverage on shares of National Grid Transco PLC (NYSE: NGG) with an “underperform” rating. National Grid Transco's shares closed at $67.32 yesterday.

Analysts at Barclays initiated coverage on shares of Varonis (NASDAQ: VRNS) with an “equal-weight” rating. The target price for Varonis is set to $42. Varonis' shares closed at $36.51 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (NGG + FEYE)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters